UPDATE: UBS Starts HEALTHSOUTH (HLS) at Buy; Compelling Demographic Trends

Article Stock Quotes (1) Comments (0)

(Updated - July 3, 2012 12:47 PM EDT)

UBS initiates coverage on HEALTHSOUTH (NYSE: HLS) with a Buy. PT $30.00.

Analyst, A.J. Rice, said, "HLS should continue to benefit from the aging of America and the desire of seniors to maintain an active lifestyle...Given strong operating trends, we would not be surprised to see positive estimate revisions at HLS as the year progresses. The company did not raise its 2012 guidance despite reporting strong 1Q12 results. Resolution of the company’s long-standing arbitration with its former auditors, Ernst & Young, could be a further positive catalyst for the HLS shares and also drive a positive estimate revision."

For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.

Shares of HEALTHSOUTH closed at $23.35 yesterday, with a 52 week range of $13.65-$27.16.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
• UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
• First Analysis Starts Digi International (DGII) at Equal Weight

Create E-mail Alert Related Categories

New Coverage

Related Entities

UBS

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?